clopidogrel has been researched along with mdv 3100 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerrigter, E; Hamberg, P; Ras, S; van Erp, NP; Verhulst, SH | 1 |
1 other study(ies) available for clopidogrel and mdv 3100
| Article | Year |
|---|---|
Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report.
Topics: Benzamides; Clopidogrel; Cytochrome P-450 CYP2C8; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant | 2022 |